MOG-Peptid 35-55

MOG-Peptid 35-55
€115.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP10354_1
Myelin oligodendrocyte glycoprotein (MOG)35-55, a minor component of CNS myelin, is expressed in... more
Product information "MOG-Peptid 35-55"
Myelin oligodendrocyte glycoprotein (MOG)35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 35-55 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 35-55 peptide can be use to induced polyclonal anti-MOG 35-55 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 35-55 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 35-55 induced experimental autoimmune encephalomyelitis (EAE) rodent models

Delivery: 2-3 days
Amount:1 mg
Counter Ion:Acetate
Protein:Myelin oligodendrocyte glycoprotein
Species:Mouse, Rat
Application :Multiple Sclerosis
MOG 35-55 MOG 35-55
From €115.00 *
MOG 35-55 MOG 35-55
From €115.00 *
P60 217-225 (H-2Kd) P60 217-225 (H-2Kd)
From €57.50 *
SNTB2 (351-360) SNTB2 (351-360)
From €57.50 *